April 18, 2023 — Medtronic today announced the 12-month findings that supported the Affera Mapping and Ablation System CE Mark, demonstrating that the Sphere-9 Catheter can successfully treat patients with either paroxysmal or persistent atrial fibrillation (AFib) using a variety of ablation lesion sets.
